Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Presentation A 35-year-old man presented to the doctor with complaints of fever, sore throat, cough, diarrhea, and a rash that developed over the prior 2

The addition of nivolumab (Opdivo) to tivozanib (Fotivda) compared with tivozanib alone failed to improve outcomes as second- or third-line treatment for patients with renal

No­var­tis is plan­ning on spin­ning off its gener­ic and biosim­i­lars arm San­doz around Oct. 4 of this year, and it will be list­ed on the